2 incredible growth stocks that AI could make even stronger

Here are a pair of top growth stocks that have very wide and deep ‘moats’, with a few crocodiles thrown in for good measure.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Man thinking about artificial intelligence investing algorithms

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Some growth stocks fizzle out quickly, while others consistently deliver strong returns over time. How can I tell the difference in advance?

Investing legend Warren Buffett can help here. He looks for businesses with deep competitive advantages or ‘moats’, akin to medieval castles defending against invaders.

Here are two deep-moat growth companies that are using artificial intelligence (AI) to strengthen their business models.

Intuitive Surgical

The first is Intuitive Surgical (NASDAQ: ISRG). The company makes state-of-the-art robotic systems that assist surgeons in carrying out minimally invasive procedures (less skin cutting). Its flagship product is the da Vinci surgical system.

Minimally invasive surgery results in quicker recovery for patients and less time spent in hospitals. And Intuitive is a global leader with an installed base of nearly 9,000 robots.

Last year, more than 2.2m procedures were carried out with its products, up 22% on the year before. This year, the company expects worldwide procedures to increase another 13%-16%.

That’s good because the more procedures taking place, the more the company earns through the sale of consumable accessories needed for surgery.

These are highly complex machines that are very difficult to get regulatory approval for. Meanwhile, surgeons trained to use them are unlikely to switch for obvious reasons. So the moats here are high barriers to entry and switching costs.

One risk is another pandemic. The last one hit the firm’s growth as surgical procedures ground to a halt. It’ll take years for hospitals to clear backlogs (with help from da Vinci, of course!).

Its next-generation machine boasts significantly more computing power. This allows for the collection of more data during surgery, which can be used for AI-based analysis. This means the system will improve over time through software and enhanced capabilities. Good luck trying to compete with that!

The stock isn’t cheap (it never has been), but it’s one I intend to hold for years as robotic-assisted surgery increasingly replaces the age-old method.

Axon Enterprise

The second stock is Axon Enterprise (NASDAQ: AXON). The firm used to be called Taser International, though today it offers various cloud-based software products beyond its legacy stun guns.

First-quarter revenue grew 34% year on year to $461m.

Axon’s wide moat comes from its ecosystem that also includes vehicle and body-worn cameras. Data gathered from these devices is stored in its digital evidence management platform (Axon Cloud).

This integrated approach creates high switching costs for law enforcement customers who would face disruption if they migrated elsewhere.

Indeed, the company has caught the attention of regulators who have tried (but so far failed) to create competition. They could try again, which is a risk.

Axon’s latest innovation is Draft One, an AI-powered software product that creates police reports in seconds based on auto-transcribed body-cam audio. This potentially saves each officer 15 hours per week in productivity gains!

One Colorado police sergeant reckons this is a game-changer: “With over 27 years of experience in law enforcement, I have seen technology come and go, but Draft One is one of the most exciting innovations for law enforcement I have ever seen“.

Only Axon has the data necessary to build such products. Through them, it’s essentially adding crocodiles to its already deep moat. That’s likely to work out well for shareholders in the long run.

More on Investing Articles

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

£1,000 buys 11,500 shares in this red hot healthcare penny stock that’s smashing GSK

This healthcare stock has delivered around twice the return of GSK shares in 2026. Believe it or not though, it…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

This little known UK growth share is up 387% in five years. Time to buy?

Christopher Ruane looks at some pros and cons of a UK growth share that has been increasing its revenues significantly.…

Read more »

National Grid engineers at a substation
Investing Articles

Here’s how long it might take 100 National Grid shares to pay for themselves with dividends

With a dividend policy that aims to keep pace with inflation, National Grid shares appeal to some income investors. What…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Under £5 now, are Barclays shares a screaming bargain following excellent 2025 results?

Barclays shares still look way too low to me, given rising earnings and big capital returns ahead — raising the…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Just a £5,000 holding in BP shares could generate £1,807 in annual income for investors over time!

BP shares are throwing off far more dividend income than most investors realise -- and the latest numbers hint the…

Read more »

Middle aged businesswoman using laptop while working from home
Investing Articles

I’m itching to buy Barclays for my Stocks and Shares ISA. But am I too late?

Harvey Jones is looking to generate some income and growth from this year Stocks and Shares ISA allowance. But is…

Read more »

Two white male workmen working on site at an oil rig
Investing Articles

Why ‘HALO’ shares could be the FTSE 100’s biggest winners in 2026

The investment environment is changing rapidly due to AI disruption concerns. Amid this backdrop, there are certain FTSE 100 shares…

Read more »

Investing Articles

Below £151, here’s why AstraZeneca’s share price looks a steal to me under £228.62 after strong 2025 results

AstraZeneca's share price looks anchored to an outdated story — and the latest results suggest the market may be missing…

Read more »